Last reviewed · How we verify
BICX104 naltrexone implantable pellet
BICX104 naltrexone implantable pellet is a Small molecule drug developed by BioCorRx Pharmaceuticals Inc. It is currently in Phase 1 development.
At a glance
| Generic name | BICX104 naltrexone implantable pellet |
|---|---|
| Sponsor | BioCorRx Pharmaceuticals Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BICX104 naltrexone implantable pellet CI brief — competitive landscape report
- BICX104 naltrexone implantable pellet updates RSS · CI watch RSS
- BioCorRx Pharmaceuticals Inc portfolio CI
Frequently asked questions about BICX104 naltrexone implantable pellet
What is BICX104 naltrexone implantable pellet?
BICX104 naltrexone implantable pellet is a Small molecule drug developed by BioCorRx Pharmaceuticals Inc.
Who makes BICX104 naltrexone implantable pellet?
BICX104 naltrexone implantable pellet is developed by BioCorRx Pharmaceuticals Inc (see full BioCorRx Pharmaceuticals Inc pipeline at /company/biocorrx-pharmaceuticals-inc).
What development phase is BICX104 naltrexone implantable pellet in?
BICX104 naltrexone implantable pellet is in Phase 1.